September 4, 2025 · Form 4 insider transaction
Cannon Gillian bought 11,000 shares of Corcept Therapeutics Incorporated at $22.99 per share, a transaction worth $252.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.